ASH Meeting – Dec 5-8, 2020 CanVECTOR Oral & Poster Presentations Day / Time / Session Title Presenter Wednesday – December 2 December 2- 7:05 AM-8:30 AM The Immunohemostatic Response to Ed Pryzdial, PhD Infection Overview Program: Scientific Workshops @ ASH Session: The Immunohemostatic Response to Infection Friday – December 4 December 4 - 7:05 AM-8:05 AM Approach to Pregnancy and Delivery in Michelle Sholzberg, MDCM, FRCPC, MSc Women with Bleeding Disorders Program: Scientific Workshops @ ASH Session: Thrombosis and Bleeding in Pregnancy Prevention and Treatment of Venous Leslie Skeith, MD Thromboembolism in Pregnancy Saturday – December 5 December 5 - 7:00 AM-3:30 PM A Retrospective Cohort Study Evaluating the Kanza Naveed, Grace H Tang, MSc, McKenzie Safety and Efficacy of Peri-Partum Quevillon, RN, BScN, MN, Filomena Meffe, MD, MSc, Program: Oral and Poster Abstracts Tranexamic Acid for Women with Inherited Rachel Martin, MD, Jillian M Baker, MD, MSc, and Bleeding Disorders Michelle Sholzberg, MDCM, FRCPC, MSc Session: 322. Disorders of Coagulation or Fibrinolysis: Poster I Number: 863 Page 1 of 7 Day / Time / Session Title Presenter December 5 - 7:00 AM-3:30 PM A Retrospective Cohort Study Evaluating the Kanza Naveed, Grace H Tang, MSc, McKenzie Safety and Efficacy of Peri-Partum Quevillon, RN, BScN, MN, Filomena Meffe, MD, MSc, Program: Oral and Poster Abstracts Tranexamic Acid for Women with Inherited Rachel Martin, MD, Jillian M Baker, MD, MSc, and Bleeding Disorders Michelle Sholzberg, MDCM, FRCPC, MSc Session: 322. Disorders of Coagulation or Fibrinolysis: Poster I Number: 863 Frequency of Venous Thromboembolism in Mark Crowther, MD, David A. Garcia, MD, Jason 6513 Patients with COVID-19: A Hill, MD, MSc, Bryan Savage, Shira Peress, Kevin Retrospective Study Chang and Steven Deitelzweig, MD Number: 875 Potency-Adjusted Analyses of a Head-to- Alexander Solms, Anita Shah, Sara Wiegmann, Head Pharmacokinetic Study of Damoctocog Maurice Ahsman, Erik Berntorp, Andreas Tiede, MD, Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfonso Iorio, MD, PhD, Maria Elisa Mancuso, Alfa (rFVIIIFc) in Patients with Severe Tihomir Zhivkov and Toshko Lissitchkov Hemophilia A Number: 878 December 5 - 7:00 AM-3:30 PM Efficacy and Safety of Tinzaparin in CAT Agnes Y. Lee, MD, MSc, Pieter W. Kamphuisen, MD, Patients with Metastatic Disease PhD, Rupert Bauersachs, MD, PhD, Karen Turpin, Program: Oral and Poster Abstracts BScN, MSc, Jes Birger Hansen and Alok A Khorana, MD Session: 332. Anticoagulation and Antithrombotic Therapy: Poster I Number: 887 December 5 - 7:00 AM-3:30 PM Thrombotic Complications in a Canadian Camille Simard, MD, Maral Koolian, MD, MSc, Population of Critically Ill Patients with FRCPC, Diana Escobar, MD, Mark Blostein, MD Program: Oral and Poster Abstracts COVID-19 FRCPC, Jed Lipes, MD, FRCPC, Adelina Teona Avram, MD, Ryan Kerzner, B Pharm, MSc, Helen Session: 332. Anticoagulation and Antithrombotic Mantzanis, B Pharm, MSc, Mateo Porres Aguilar, Therapy: Poster I MD and Vicky Tagalakis, MD, FRCPC Number: 896 Page 2 of 7 Day / Time / Session Title Presenter December 5 - 7:00 AM-3:30 PM The Prognostic Validity of the Acute Myeloid Shannon Murphy, MD, MBA, Brian Harnett, MD, Kara Leukemia Composite Model in Predicting Matheson, David M. Jones, MD, Abdulrahim Program: Oral and Poster Abstracts Risks of One-Year Mortality Among Patients Basendwah, MD, Sudeep P Shivakumar, MD, BSc in Atlantic Canada: A Multi-Centre and Mahmoud Elsawy, MB Session: 613. Acute Myeloid Leukemia: Clinical Experience Studies: Poster I Number: 999 December 5 - 7:00 AM-3:30 PM Detection of Right Ventricular Dysfunction in Nicholas L Jackson Chornenki, MD, Khashayar Acute Pulmonary Embolism By CT Scan: A Poorzargar, Maaz Shanjer, Lawrence Mbuagbaw, Program: Oral and Poster Abstracts Systematic Review and Meta-Analysis Mark Crowther, MD and Deborah M Siegal, MD Session: 901. Health Services Research—Non- Number: 1573 Malignant Conditions: Poster I December 5 - 7:00 AM-3:30 PM Reducing Cytogenetic Testing in the Era of Eri Kawata, MD, PhD, Benjamin Hedley, PhD, Next Generation Sequencing (NGS); Are We Benjamin Chin-Yee, MD, Anargyros Xenocostas, MD, Program: Oral and Poster Abstracts Choosing Wisely? FRCPC, Alejandro Lazo-Langner, MD, MSc, Cyrus C. Hsia, MD, BSc, FRCPC, Kang Howson-Jan, MD, Session: 903. Health Services Research— FRCPC, Ping Yang, PhD, DABMGG, Michael Levy, Malignant Conditions (Myeloid Disease): Poster I PhD, Stephanie Santos, Chris Howlett, Hanxin Lin, PhD, Bekim Sadikovic, PhD, DABMGG, FACMG and Ian Chin-Yee, MD, FRCPC Number: 1612 December 5 - 12:00 PM Impact of Thromboembolism on Overall and Marie-Claude Pelland-Marcotte, MD, PhD, Ketan Event-Free Survival in Children with Acute Kulkarni, MD, Uma Athale, MD, MBBS, MSc, Jason Program: Oral and Poster Abstracts Lymphoblastic Pole, PhD, Leonardo R. Brandao, MD and Lillian Sung, MD, PhD Type: Oral Number: 201 Session: 904. Outcomes Research - Non-Malignant Conditions: Venous Thromboembolism Associated with Cancer and/or COVID-19 Page 3 of 7 Day / Time / Session Title Presenter December 5 - 2:15 PM Safety and Efficacy of the Contact Activation Christina U Lorentz, PhD1, Norah G Verbout, PhD1, Inhibitor AB023 in Patients with End-Stage Joseph J Shatzel, MD, Michael Wallisch, PhD1, Program: Oral and Poster Abstracts Renal Disease on Chronic Hemodialysis: A Brandon D Markway, PhD, Monica T Hinds, PhD, Type: Oral Phase 2, Double-Blind, Randomized, Placebo- Owen J T McCarty, PhD, David Gailani, MD, Jeffrey I. Controlled Trial Weitz, MD, FRCPC, Erik I Tucker, PhD and András Session: 332. Anticoagulation and Antithrombotic Gruber, MD Therapy: Novel Agents, Reversal Drugs and Indications Number 237 December 5 - 3:00 PM Not All Patients Benefit from Switching to Olav Versloot, MSc., Emma Iserman, Pierre Chelle, Ehl: Results from the Wapps Database PhD, Federico Germini, MD, MSc, Tushara Mathew, Program: Oral and Poster Abstracts Alfonso Iorio, MD, PhD, and Kathelijn Fischer Type: Oral Number 234 Session: 332. Anticoagulation and Antithrombotic Therapy: Novel Agents, Reversal Drugs and Indications December 5 - 3:15 PM Terminal Half-Life of Factor VIII/IX Olav Versloot, MSc., Emma Iserman, Pierre Chelle, According to Age and Blood Group Based on PhD, Federico Germini, MD, MSc Tushara Mathew, Program: Oral and Poster Abstracts 8550 Assessments Alfonso Iorio, MD, PhD and Kathelijn Fischer Type: Oral Number 235 Session: 322. Disorders of Coagulation or Fibrinolysis: Hemophilia: Genes, Joints, and PK Sunday – December 6 December 6 - 7:00 AM-3:30 PM Analysis of Hemophilia a Outcomes and Adrienne Lee, MD, Federico Germini, MD, MSc, Treatment Patterns Using Real-World Data Man-Chiu Poon, MD, Arun Keepanasseril, Quazi Program: Oral and Poster Abstracts from the Canadian Hemophilia Bleeding Ibrahim, MSc, Aijing Shang, MD, PhD, Francis Nissen, Disorder Registry Oliver Meier, Cami S. Sima, MD, Davide Matino and Session: 322. Disorders of Coagulation or Alfonso Iorio, MD, PhD Fibrinolysis: Poster II Number: 1793 Page 4 of 7 Day / Time / Session Title Presenter December 6 - 7:00 AM-3:30 PM A Retrospective Review of the Monika Oliver, MD, BSc, Mariam Goubran, BSc, Appropriateness of D-Dimer Ordering and Jacqueline Karathra, BMSc, Mohammad Karkhaneh, Program: Oral and Poster Abstracts Interpretation Using Wells' Clinical PhD and Cynthia M. Wu, MD, FRCPC Probability Criteria Session: 901. Health Services Research—Non- Number: 2483 Malignant Conditions: Poster II Patient Adherence to Medication within a Kwadwo Osei Bonsu, BPharm(Hons), PhD, New Multidisciplinary Thrombosis Service Stephanie W Young, PharmD, Tiffany Lee, BSc(Pharm), Pharm.D, Hai V Nguyen, PhD and Rufaro S Chitsike, MBChB, MMed(Haem), FCPath(Haem), Cert Clin(Haem) Number: 2493 December 6 - 7:00 AM-3:30 PM Association between Aging and Health Status Federico Germini, MD, MSc, Suzanne O'Callaghan, in Persons Living with Hemophilia and BA, Chatree Chai-Adisaksopha, MD, PhD, Randall Program: Oral and Poster Abstracts Controls without a Bleeding Disorder – Curtis, MB, Neil Frick, Michael B. Nichol, PhD, Declan Insights from the Probe Study Noone, MSc, Brian O'Mahony, David Page, Jeffrey Session: 904. Outcomes Research—Non- Stonebraker, Mark W Skinner, JD, and Alfonso Malignant Conditions: Poster II Iorio, MD, PhD Number: 2529 December 6 - 12:00 PM Suboptimal Screening for Iron Deficiency in Jennifer Teichman, MD, Michelle Sholzberg, Pregnancy in a High Resource Setting MDCM, FRCPC, MSc, Rosane Nisenbaum, PhD and Program: Oral and Poster Abstracts Andrea Lausman, MD, FRCSC Type: Oral Number 424 Session: 901. Health Services Research—Non- Malignant Conditions II Page 5 of 7 Day / Time / Session Title Presenter December 6 - 1:15 PM Deep Vein Thrombosis Diagnosis with D- Kerstin de Wit, MBChB, MDm MSc, Sameer Dimer Adjusted to Clinical Probability Parpia, Sam Schulman, MD, PhD, FRCPC, Fred Program: Oral and Poster Abstracts Spencer, MD, FRCP, Sangita Sharma, Marc Afilalo, Susan Kahn, MD, Gregoire Le Gal, MD, PhD, Type: Oral Sudeep P Shivakumar, MD, BSc, Shannon M. Bates, MD, FRCPC, MSc, Cynthia M. Wu, MD, Session: 901. Health Services Research—Non- FRCPC, Alejandro Lazo-Langner, MD, MSc, Malignant Conditions II Frederick D’Aragon, MD, Jean-Francois Deshaies, Luciana Spadafora, Jim Julian and Clive Kearon, MB, PhD Number 429 Monday – December 7 December 7 - 7:00 AM-3:30 PM Platelet Membrane Procoagulation in Adrienne Lee, MD, Lorriane Chow, BSc, MD, FRCPC, Preeclampsia Leslie Skeith, MD, Joshua A Nicholas, BHSc, MD, Program: Oral and Poster Abstracts Man-Chiu